IRIS
D'EGIDIO, Maurizia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 462
EU - Europa 358
AS - Asia 169
OC - Oceania 1
Totale 990
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 462
CN - Cina 65
IE - Irlanda 65
UA - Ucraina 60
SE - Svezia 49
SG - Singapore 47
GB - Regno Unito 46
FR - Francia 42
IT - Italia 40
TR - Turchia 38
DE - Germania 19
IN - India 13
BE - Belgio 10
CZ - Repubblica Ceca 9
FI - Finlandia 9
RU - Federazione Russa 6
VN - Vietnam 4
HK - Hong Kong 2
NL - Olanda 2
AU - Australia 1
ES - Italia 1
Totale 990
Salva come PNG Salva come JPEG
Città #
Chandler 81
Jacksonville 67
Dublin 65
Ann Arbor 55
Singapore 45
Southend 38
New York 28
Princeton 26
Izmir 18
Nanjing 18
Wilmington 18
Ashburn 14
Woodbridge 14
Dearborn 12
Beijing 10
Brussels 10
Cambridge 10
Altamura 9
Nanchang 9
Santa Clara 9
Boardman 8
Brno 8
Chieti 7
Los Angeles 5
Dong Ket 4
Hangzhou 4
Changsha 3
Città Sant'Angelo 3
Düsseldorf 3
Jiaxing 3
Kunming 3
Norwalk 3
Collecorvino 2
Edinburgh 2
Hebei 2
Hong Kong 2
Houston 2
Jinan 2
Kocaeli 2
Lanzhou 2
Munich 2
San Mateo 2
Seattle 2
Shenyang 2
Tianjin 2
Auburn Hills 1
Castellamonte 1
Changchun 1
Frascati 1
Laurel 1
Leawood 1
Madrid 1
Martano 1
Mcallen 1
Montesilvano Marina 1
Ningbo 1
Odesa 1
Olomouc 1
Paris 1
Pescara 1
Pune 1
Pusiano 1
Rome 1
Shanghai 1
Totale 655
Salva come PNG Salva come JPEG
Nome #
The 90K tumor associated antigen and clinical progression in human immunodeficiency virus infection 98
Purification and characterization of a 90 kDa protein releasedfrom human tumors and tumor cell lines 98
Prognostic relevance of LGALS3BP in human colorectal carcinoma 97
Elevated serum levels of 90K/MAC-2BP predict unresponsiveness to alfa-interferon therapy in chronic HCV hepatitis patients 93
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody. 85
LGALS3BP, A TUMOR-ASSOCIATED ANTIGEN, UPREGULATES VEGF IN HUMAN BREAST CANCER: POSSIBLE IMPLICATIONS IN ANGIOGENESIS 74
BIOLOGICAL INDICATORS OF PROGNOSIS IN HUMAN CANCER: AN EMERGING ROLE FOR LECTIN GALACTOSIDE-BINDING SOLUBLE 3-BINDING PROTEIN (LGALS3BP) 73
Synthetic lactulose amines: novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis. 71
Elevated serum levels of a 90,000 daltons tumor-associated antigen in cancer and in infection by human immunodeficiency virus (HIV). 69
Inhibition of tumor growth and angiogenesis by SP-2, an anti-LGALS3BP antibody 67
An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling. 56
Identification of the tumor antigen 90K domains recognized by monoclonal antibodies SP2 and L3 and preparation and characterization of novel anti-90k monoclonal antibodies 54
Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression 50
Effects of an ErbB-3 antibody, MP-RM-1, on tumor growth and ligand-dependent and -independent activation of ErbB-3/akt signaling 25
90K immunostimulatory glycoprotein in children with juvenile idiopathic arthritis 19
Totale 1.029
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.890
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020108 0 0 0 4 18 14 24 16 7 9 15 1
2020/202190 11 4 13 3 9 15 5 2 7 11 4 6
2021/202278 2 1 2 15 8 8 6 8 5 2 6 15
2022/2023224 15 33 21 22 22 36 11 18 29 0 11 6
2023/2024154 11 5 11 8 2 64 23 7 2 2 1 18
2024/202590 13 44 31 2 0 0 0 0 0 0 0 0
Totale 1.029